Fig. 3
Last known status in the longitudinal cohort (patients with significant memory complaint/patients with mild cognitive impairment [MCI]) according to baseline positron emission tomography (PET) profile (assessed using composite standardised uptake value ratio with a cut-off at 0.89) and cerebrospinal fluid profile in terms of amyloid-β1–42 (Aβ/tau) combination. AD Alzheimer’s disease, NL Normal